Associations between dysbiosis-inducing drugs, overall survival and tumor response in patients treated with immune checkpoint inhibitors

BACKGROUND: There are conflicting data on the effects of dysbiosis-inducing drugs, and especially antibiotics (ATBs), on clinical outcomes in patients treated with immune checkpoint inhibitors (ICIs). There is a particular lack of data for patients with melanoma. METHODS: We performed a single-cente...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Ther Adv Med Oncol
Autors principals: Gaucher, Louis, Adda, Leslie, Séjourné, Alice, Joachim, Camille, Guillaume, Chaby, Poulet, Claire, Liabeuf, Sophie, Gras-Champel, Valérie, Masmoudi, Kamel, Houessinon, Aline, Bennis, Youssef, Batteux, Benjamin
Format: Artigo
Idioma:Inglês
Publicat: SAGE Publications 2021
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7968039/
https://ncbi.nlm.nih.gov/pubmed/33796151
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/17588359211000591
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars